کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2474550 | 1113147 | 2013 | 5 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: A cell-based fluorescent glucose transporter assay for SGLT2 inhibitor discovery A cell-based fluorescent glucose transporter assay for SGLT2 inhibitor discovery](/preview/png/2474550.png)
The sodium/glucose cotransporter 2 (SGLT2) is responsible for the majority of glucose reabsorption in the kidney, and currently, SGLT2 inhibitors are considered as promising hypoglycemic agents for the treatment of type 2 diabetes mellitus. By constructing CHO cell lines that stably express the human SGLT2 transmembrane protein, along with a fluorescent glucose transporter assay that uses 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]2-deoxyglucose (2-NBDG) as a glucose analog, we have developed a nonradioactive, cell-based assay for the discovery and characterization of SGLT2 inhibitors.
A nonradioactive, cell-based assay for the discovery and characterization of SGLT2 inhibitors was developed using 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]2-deoxyglucose (2-NBDG) as a glucose analog.Figure optionsDownload as PowerPoint slide
Journal: Acta Pharmaceutica Sinica B - Volume 3, Issue 2, April 2013, Pages 97–101